Cargando…
Bidirectional regulation of adenosine 5′‐monophosphate–activated protein kinase activity by berberine and metformin in response to changes in ambient glucose concentration
Both berberine and metformin are well‐known antihyperglycemic agents for diabetes treatment. Adenosine monophosphate (AMP)‐activated protein kinase (AMPK) activation is often considered as the most important molecular mechanism although the mechanism has been challenged recently. Up to now, when the...
Autores principales: | Xiao, Yuanyuan, Xu, Miao, Alimujiang, Miriayi, Bao, Yuqian, Wei, Li, Yin, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282525/ https://www.ncbi.nlm.nih.gov/pubmed/30129983 http://dx.doi.org/10.1002/jcb.27312 |
Ejemplares similares
-
Berberine alleviates lipid metabolism disorders via inhibition of mitochondrial complex I in gut and liver
por: Yu, Muyu, et al.
Publicado: (2021) -
Metformin activates type I interferon signaling against HCV via activation of adenosine monophosphate-activated protein kinase
por: Tsai, Wei-Lun, et al.
Publicado: (2017) -
Metformin directly suppresses atherosclerosis in normoglycaemic mice via haematopoietic adenosine monophosphate-activated protein kinase
por: Seneviratne, Anusha, et al.
Publicado: (2020) -
Adenosine monophosphate–activated protein kinase in diabetic nephropathy
por: Kim, Yaeni, et al.
Publicado: (2016) -
Roles of adenosine monophosphate-activated protein kinase (AMPK) in the kidney
por: Zhu, Na, et al.
Publicado: (2022)